Sign in to view content

Impact of Delayed Treatment in Diabetic Retinal Disease: Experience From VISTA/VIVID and PANORAMA

Sunil Srivastava, MD

Video
Published 2021

Related

Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months
Brittney Statler, MD
Updates from the Field
2020
Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2021
Risk of Diabetic Retinopathy Progression in Patients During 1 year of Semaglutide Use
Blake A. Cooper, MD MPH
Updates from the Field
2022

Category: Diabetic Retinopathy

See more